PubMed Health⌕ Search

PubMed · 788521

Preventing enamel decalcification during orthodontic treatment.

Abstract

One hundred thirty-two extracted premolar teeth were selected and divided into four equal groups. The first group of thirty-three teeth received a topical application of acidulated phosphate fluoride; the second group, a topical application of stannous fluoride; the third group, an application of a polymeric adhesive coating; the fourth group was left untreated to serve as a control. On each tooth a loosely fitted orthodontic band was cemented to place. After cementation, the band was broken to simulate a loose orthodontic band in vivo. The four groups of teeth were simultaneously immersed in a decalcifying gelatin and were left undisturbed for 11 weeks. The teeth were then removed and a record was made of the decalcification produced. A chi-square test was used to compare the teeth in each group to those in every other group. Compared to a control group of teeth, those teeth treated with polymeric adhesive coating, acidulated phosphate fluoride, or stannous fluoride produced a statistically significant reduction in decalcification of the tooth surfaces beneath loose orthodontic bands. For a one-application technique, the polymeric adhesive coating provided more protection against decalcification of teeth under loose orthondontic bands than did either acidulated phosphate fluoride or stannous flouride.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

T J Tillery, J H Hembree, F N Weber. 1976. Preventing enamel decalcification during orthodontic treatment.. https://doi.org/10.1016/0002-9416(76)90116-0

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Superimposition of nutcracker syndrome in a hematuric child with idiopathic hypercalciuria and urolithiasis.

We report a 5-year-old girl with idiopathic hypercalciuria who developed gross hematuria and left flank pain despite normalization of calciuria, a renal stone, and microscopic hematuria. She was found to have nutcracker syndrome by renal Doppler ultrasound, which revealed the significant differences of the peak blood flow velocities in the two portions of the left renal vein.

Calcium Metabolism Disorders↗

The calcium-sensing receptor and related diseases.

The calcium-sensing receptor (CASR) adjusts the extracellular calcium set point regulating PTH secretion and renal calcium excretion. The receptor is expressed in several tissues and is also involved in other cellular functions such as proliferation, differentiation and other hormonal secretion. High extracellular calcium levels activate the receptor resulting in modulation of several signaling pathways depending on the target tissues. Mutations in the CASR gene can result in gain or loss of receptor function. Gain of function mutations are associated to Autossomal dominant hypocalcemia and Bartter syndrome type V, while loss of function mutations are associated to Familial hypocalciuric hypercalcemia and Neonatal severe hyperparathyroidism. More than one hundred mutations were described in this gene. In addition to calcium, the receptor also interacts with several ions and polyamines. The CASR is a potential therapeutic target to treatment of diseases including hyperparathyroidism and osteoporosis, since its interaction with pharmacological compounds results in modulation of PTH secretion.

Calcium Metabolism Disorders↗